TY - JOUR
T1 - Inhibition of bone morphogenetic protein-induced osteoblast differentiation
AU - Kokabu, Shoichiro
AU - Tsuchiya-Hirata, Shizu
AU - Fukushima, Hidefumi
AU - Sugiyama, Goro
AU - Lowery, Jonathan W.
AU - Katagiri, Takenobu
AU - Jimi, Eijiro
N1 - Funding Information:
We thank the members of the Division of Molecular Signaling and Biochemistry, Department of Health Promotion, Kyushu Dental University; Department of Oral and Maxillofacial, Faculty of Medicine, Saitama Medical University; Division of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University; and Harvard School of Dental Medicine for their valuable comments and discussion. S. Kokabu and J.W. Lowery were supported by a Dean׳s Scholar Award at the Harvard School of Dental Medicine (2013).
Publisher Copyright:
© 2015 Japanese Association for Oral Biology.
PY - 2015
Y1 - 2015
N2 - Background Bone morphogenetic proteins (BMPs) induce ectopic bone formation in vivo and osteoblast differentiation of various cells in vitro. Therefore, BMPs are thought to be useful in bone regeneration medicine and for treating bone-related diseases. However, clinical application of BMPs is not widespread. Highlight BMP signal transduction and BMP-induced osteoblast differentiation are negatively regulated at several steps. BMP-3 acts as an antagonist to activin receptor type 2B and suppresses osteoblast differentiation of bone marrow stromal cells (BMSCs). Targeted disruption of Bmp-3 in mice increases trabecular bone formation and bone mass. A selective inhibitor of classical NF-κB pathway enhances BMP-2-induced ectopic bone formation in vivo. NF-κB inhibits BMP-induced osteoblast differentiation by directly targeting SMAD proteins. p65, the main subunit of NF-κB, interacts with SMAD4 and interferes with the DNA binding of SMAD complex, thus suppressing BMP-induced osteoblast differentiation. Transducin-like enhancer of split 3 (TLE3), a member of Groucho/TLE family, represses the transactivation of RUNX2, one of the master regulators of osteoblast differentiation, thus suppressing BMP-induced osteoblast differentiation of BMSCs. Conclusion In addition to BMP-3, NF-κB, and TLE3, numerous inhibitors suppress BMP-induced osteoblast differentiation. Therefore, a precise understanding of mechanisms underlying the inhibition of osteoblast differentiation may help develop novel methods for treating bone-related diseases or for the tissue engineering of the bone.
AB - Background Bone morphogenetic proteins (BMPs) induce ectopic bone formation in vivo and osteoblast differentiation of various cells in vitro. Therefore, BMPs are thought to be useful in bone regeneration medicine and for treating bone-related diseases. However, clinical application of BMPs is not widespread. Highlight BMP signal transduction and BMP-induced osteoblast differentiation are negatively regulated at several steps. BMP-3 acts as an antagonist to activin receptor type 2B and suppresses osteoblast differentiation of bone marrow stromal cells (BMSCs). Targeted disruption of Bmp-3 in mice increases trabecular bone formation and bone mass. A selective inhibitor of classical NF-κB pathway enhances BMP-2-induced ectopic bone formation in vivo. NF-κB inhibits BMP-induced osteoblast differentiation by directly targeting SMAD proteins. p65, the main subunit of NF-κB, interacts with SMAD4 and interferes with the DNA binding of SMAD complex, thus suppressing BMP-induced osteoblast differentiation. Transducin-like enhancer of split 3 (TLE3), a member of Groucho/TLE family, represses the transactivation of RUNX2, one of the master regulators of osteoblast differentiation, thus suppressing BMP-induced osteoblast differentiation of BMSCs. Conclusion In addition to BMP-3, NF-κB, and TLE3, numerous inhibitors suppress BMP-induced osteoblast differentiation. Therefore, a precise understanding of mechanisms underlying the inhibition of osteoblast differentiation may help develop novel methods for treating bone-related diseases or for the tissue engineering of the bone.
UR - http://www.scopus.com/inward/record.url?scp=84952631186&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952631186&partnerID=8YFLogxK
U2 - 10.1016/j.job.2015.05.005
DO - 10.1016/j.job.2015.05.005
M3 - Review article
AN - SCOPUS:84952631186
VL - 57
SP - 179
EP - 184
JO - Journal of Oral Biosciences
JF - Journal of Oral Biosciences
SN - 1349-0079
IS - 4
ER -